|
ATP1B3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.220600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.146600E-01 |
| Normal-vs-Stage2 |
7.470400E-01 |
| Normal-vs-Stage3 |
1.246000E-01 |
| Normal-vs-Stage4 |
3.662400E-02 |
| Stage1-vs-Stage2 |
3.012600E-01 |
| Stage1-vs-Stage3 |
9.512100E-02 |
| Stage1-vs-Stage4 |
2.892400E-02 |
| Stage2-vs-Stage3 |
5.062200E-02 |
| Stage2-vs-Stage4 |
1.646180E-02 |
| Stage3-vs-Stage4 |
2.293200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.519430E-01 |
| Normal-vs-AfricanAmerican |
4.848200E-01 |
| Normal-vs-Asian |
2.771400E-01 |
| Caucasian-vs-AfricanAmerican |
3.641800E-01 |
| Caucasian-vs-Asian |
4.615600E-01 |
| AfricanAmerican-vs-Asian |
6.117800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.520200E-01 |
| Normal-vs-Female |
2.203000E-01 |
| Male-vs-Female |
9.492000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.782600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.997650E-01 |
| Normal-vs-Age(61-80Yrs) |
2.625400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.222000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.473200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.388000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.106800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.041000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.473800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.725400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.081800E-02 |
| Classical-VS-Follicular |
1.99970040526409E-10 |
| Classical-VS-Other |
7.911800E-01 |
| Classical-VS-Normal |
8.674200E-02 |
| Tall-VS-Follicular |
1.54529999907282E-09 |
| Tall-VS-Other |
2.101000E-01 |
| Tall-VS-Normal |
1.202300E-02 |
| Follicular-VS-Other |
6.965500E-02 |
| Follicular-VS-Normal |
4.621200E-01 |
| Other-VS-Normal |
3.901400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.193800E-01 |
| Normal-vs-N1 |
1.816180E-01 |
| N0-vs-N1 |
1.192190E-01 |
|
|
